diagnostics

Microsoft AI beats doctors on hard cases in Science study

Microsoft's AI diagnostic system correctly solved 83% of complex New England Journal of Medicine cases in a simulation. Generalist physicians using reference materials got 36% right, according to a study published Thursday, October 22, in Science. Microsoft AI CEO Mustafa…

Diagnostics firm Qiagen agrees to €10.8 billion EQT buyout

QIAGEN has agreed to be taken private by EQT in an all-cash deal. The buyout firm's EQT XI fund will offer €46.50 per share, a 40.3% premium to the Dutch-domiciled diagnostics company's unaffected share price, the companies said on October…

FDA authorizes OraSure’s rapid test for Bundibugyo Ebola virus

The FDA on Tuesday granted Emergency Use Authorization to OraSure Technologies for its OraQuick Ebola 2.0 Rapid Antigen Test, a second-generation diagnostic capable of detecting the Bundibugyo virus driving the current Ebola epidemic in Central Africa.